Showing results (271-280 of 2,280) with videos related to

Sort By:
Pageof 228
HIV Medicine|February 20, 2007
Community-based rapid HIV testing in homeless and marginally housed adults in San FranciscoJ B Buchér, K M Thomas, D Guzman, et al.
HIV Medicine|February 20, 2007
Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free HospitalC J Smith, A N Phillips, M S Youle, et al.
HIV Medicine|February 20, 2007
Safety of nevirapine in pregnancyU Natarajan, A Pym, C McDonald, et al.
HIV Medicine|November 16, 2006
Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infectionL Adalid-Peralta, L Grangeot-Keros, A Rudent, et al.
HIV Medicine|November 16, 2006
Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment responseL Fardet, M Mary-Krause, I Heard, et al.
HIV Medicine|November 21, 2008
Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patientsP Ryan, F Blanco, P García-Gascó, et al.
HIV Medicine|February 21, 2009
Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse populationTw Mahungu, Cj Smith, F Turner, et al.
HIV Medicine|February 4, 2009
Comparison of glomerular filtration rate estimates vs. 24-h creatinine clearance in HIV-positive patientsG Ravasi, M Lauriola, C Tinelli, et al.
HIV Medicine|February 10, 2009
Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapyU S Kristoffersen, K Kofoed, G Kronborg, et al.
HIV Medicine|February 10, 2009
Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruptionB Barqasho, P Nowak, A Tjernlund, et al.
Pageof 228